QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 217 filers reported holding QIAGEN NV in Q3 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $772,584,000 | – | 16,639 | +11.8% | 0.44% | – |
Q1 2022 | $0 | – | 14,886 | -47.9% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 28,548 | -47.3% | 0.00% | – |
Q3 2021 | $1,000 | – | 54,157 | +53.3% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 35,328 | -9.7% | 0.00% | -100.0% |
Q1 2021 | $1,091,671,000 | -12.4% | 39,103 | -8.4% | 0.31% | -15.0% |
Q4 2020 | $1,246,815,000 | -40.5% | 42,673 | -43.2% | 0.37% | -39.4% |
Q3 2020 | $2,093,753,000 | +451.7% | 75,105 | +427.6% | 0.61% | +500.0% |
Q2 2020 | $379,537,000 | +1046.4% | 14,234 | +344.8% | 0.10% | +1583.3% |
Q3 2018 | $33,107,000 | -70.5% | 3,200 | -11.1% | 0.01% | -66.7% |
Q2 2018 | $112,056,000 | +635.8% | 3,600 | +599.0% | 0.02% | +500.0% |
Q1 2018 | $15,229,000 | -91.7% | 515 | -89.9% | 0.00% | -90.6% |
Q4 2017 | $183,193,000 | +135.5% | 5,105 | +297.3% | 0.03% | +113.3% |
Q3 2017 | $77,790,000 | -94.5% | 1,285 | -97.0% | 0.02% | -95.0% |
Q2 2017 | $1,405,289,000 | -41.8% | 42,563 | -48.7% | 0.30% | -44.7% |
Q1 2017 | $2,412,966,000 | – | 82,944 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |